UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of a Novel c-MET-Based CTC Detection Platform

Molecular cancer research, 2016-06, Vol.14 (6), p.539-547

2016

Volltextzugriff (PDF)

Development of a method to isolate circulating tumor cells using mesenchymal-based capture

Methods (San Diego, Calif.), 2013-12, Vol.64 (2), p.129-136

2013

Volltextzugriff (PDF)

Construction of repeat-free fluorescence in situ hybridization probes

Nucleic acids research, 2012-02, Vol.40 (3), p.e20-e20

2012

Volltextzugriff (PDF)

Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration‐resistant prostate cancer (CRPC)

Cancer, 2018-03, Vol.124 (6), p.1216-1224

2018

Volltextzugriff (PDF)

Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab

Leukemia, 2021-02, Vol.35 (2), p.573-584

2021

Volltextzugriff (PDF)

Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders

British journal of haematology, 2018-01, Vol.180 (1), p.71-81

2018

Volltextzugriff (PDF)

CAR+ T-Cell Lymphoma Post Ciltacabtagene Autoleucel Therapy for Relapsed Refractory Multiple Myeloma

Blood, 2023-11, Vol.142 (Supplement 1), p.6939-6939

2023

Volltextzugriff (PDF)

Abstract 5662: JNJ-67571244: A novel anti-CD33 C2 domain binding bispecific antibody with potent T cell redirection activity

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5662-5662

2020

Volltextzugriff (PDF)

Abstract 3063: Molecular characterization of individual circulating tumor cells by RNA sequencing

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3063-3063

2014

Volltextzugriff (PDF)

Abstract 3037: Comparison of multiplexed imaging mass cytometry in FFPE tissue to monoplex immunohistochemistry

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3037-3037

2018

Volltextzugriff (PDF)

Prediction of metastatic castrate-resistant prostate cancer response to abiraterone or enzalutamide by a baseline blood-based CTC gene expression signature

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e16529-e16529

2019

Volltextzugriff (PDF)

Abstract 1597: A novel method for isolation and genetic analysis of pure populations of circulating plasma cells from multiple myeloma patients

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.1597-1597

2015

Volltextzugriff (PDF)

A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia

Blood advances, 2020-03, Vol.4 (5), p.906-919

2020

Volltextzugriff (PDF)

Automated Enumeration and Characterization of Circulating Multiple Myeloma Cells in Blood

Blood, 2011-11, Vol.118 (21), p.1825-1825

2011

Volltextzugriff (PDF)

Abstract 375: Phenotypic and molecular characterization of circulating tumor cells (CTCs) in patients with castration resistant prostate cancer (CRPC) undergoing treatment with abiraterone acetate or enzalutamide

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.375-375

2015

Volltextzugriff (PDF)

Abstract 3163: Peripheral blood circulating multiple myeloma cells (CMMCs) correlate with disease burden and can be used to characterize high-risk cytogenetics in newly diagnosed and smoldering myeloma

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3163-3163

2016

Volltextzugriff (PDF)

Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide

Prostate cancer and prostatic diseases, 2021-06, Vol.24 (2), p.448-456

2021

Volltextzugriff (PDF)

Evaluation of a novel c-MET based circulating tumor cell (CTC) biomarker in patients with gastrointestinal malignancies

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.84-84

2015

Volltextzugriff (PDF)

Evaluation of a novel c-MET based circulating tumor cell (CTC) biomarker in patients with gastrointestinal (GI) and genitourinary (GU) malignancies

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.11024-11024

2015

Volltextzugriff (PDF)

Abstract 1443: Improved molecular characterization of circulating tumor cells

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1443-1443

2013

Volltextzugriff (PDF)

Circulating Multiple Myeloma Cells (CMMCs): A Novel Method for Detection and Molecular Characterization of Peripheral Blood Plasma Cells in Multiple Myeloma Precursor States

Blood, 2014-12, Vol.124 (21), p.2031-2031

2014

Volltextzugriff (PDF)

Development and analysis of androgen receptor (AR) axis biomarkers of circulating tumor cells (CTCs) in Japanese metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate (AA)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e16032-e16032

2014

Volltextzugriff (PDF)

CELLSEARCH® Instrument, Features, and Usage

Circulating Tumor Cells, 2016, p.377-400

2016

Volltextzugriff (PDF)

Predicting Fracture in Micrometer-Scale Polycrystalline Silicon MEMS Structures

Journal of microelectromechanical systems, 2011-08, Vol.20 (4), p.922-932

2011

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)
Buchkapitel
(1)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of a Novel c-MET-Based CTC Detection Platform

Development of a method to isolate circulating tumor cells using mesenchymal-based capture

Construction of repeat-free fluorescence in situ hybridization probes

Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration‐resistant prostate cancer (CRPC)

Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab

Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders

CAR+ T-Cell Lymphoma Post Ciltacabtagene Autoleucel Therapy for Relapsed Refractory Multiple Myeloma

Biomarker Correlates of Response to Ciltacabtagene Autoleucel in Patients with Relapsed or Refractory Multiple Myeloma from CARTITUDE-1, a Phase 1b/2 Open-Label Study, at the ~3 Year Follow-up

Abstract 5662: JNJ-67571244: A novel anti-CD33 C2 domain binding bispecific antibody with potent T cell redirection activity

Abstract 3063: Molecular characterization of individual circulating tumor cells by RNA sequencing

Abstract 3037: Comparison of multiplexed imaging mass cytometry in FFPE tissue to monoplex immunohistochemistry

Prediction of metastatic castrate-resistant prostate cancer response to abiraterone or enzalutamide by a baseline blood-based CTC gene expression signature

Abstract 1597: A novel method for isolation and genetic analysis of pure populations of circulating plasma cells from multiple myeloma patients

A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia

Automated Enumeration and Characterization of Circulating Multiple Myeloma Cells in Blood

Abstract 375: Phenotypic and molecular characterization of circulating tumor cells (CTCs) in patients with castration resistant prostate cancer (CRPC) undergoing treatment with abiraterone acetate or enzalutamide

Abstract 3163: Peripheral blood circulating multiple myeloma cells (CMMCs) correlate with disease burden and can be used to characterize high-risk cytogenetics in newly diagnosed and smoldering myeloma

Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide

Evaluation of a novel c-MET based circulating tumor cell (CTC) biomarker in patients with gastrointestinal malignancies

Evaluation of a novel c-MET based circulating tumor cell (CTC) biomarker in patients with gastrointestinal (GI) and genitourinary (GU) malignancies

Abstract 1443: Improved molecular characterization of circulating tumor cells

Circulating Multiple Myeloma Cells (CMMCs): A Novel Method for Detection and Molecular Characterization of Peripheral Blood Plasma Cells in Multiple Myeloma Precursor States

Development and analysis of androgen receptor (AR) axis biomarkers of circulating tumor cells (CTCs) in Japanese metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate (AA)

CELLSEARCH® Instrument, Features, and Usage

Predicting Fracture in Micrometer-Scale Polycrystalline Silicon MEMS Structures

Suchergebnisse filtern